58-17H-51. Reclassification of benefits with respect to cancer treatment medications.
104 words·~1 min read·
/sd/title-58/chapter-58-17/58-17h-51·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
A health carrier may not reclassify benefits with respect to cancer treatment medications or increase a copayment, deductible, or coinsurance amount for covered cancer treatment medications that are injected or intravenously administered unless:
(1)The increase is applied generally to other medical or pharmaceutical benefits covered under the plan and is not done to circumvent § 58-17H-50 ;
(2)The reclassification of benefits with respect to cancer treatment medications is done in a manner that is consistent with §§ 58-17H-50 to 58-17H-52 , inclusive; or
(3)A health carrier is applying cost-sharing increases consistent with the annual increases in the cost of health care.